Credit: Getty Images. The Agency stated that it “erred in approving the indication for routine prophylaxis in children with hemophilia B” due to the Orphan Drug exclusivity. The Food and Drug ...
Wyeth says that it has assumed all marketing and distribution rights to the anticoagulant treatment BeneFIX in Europe for patients with haemophilia B. Wyeth says that it has assumed all marketing and ...
Enhancements Provide Haemophilia B Patients with a Simpler and More Convenient Preparation Process for Recombinant Factor IX MAIDENHEAD, England, August 20 -- Wyeth Pharmaceuticals, a division of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results